Skip to main content
Industry News
Brain tumor gene therapy nabs rare pediatric disease tag
9/15/2020

The FDA awarded rare pediatric disease designation to Ziopharm Oncology's investigational gene therapy veledimex (Controlled IL-12) with Ad-RTS-hIL-12, a treatment for diffuse intrinsic pontine glioma, a type of brain tumor that accounts for about 10% to 15% of all brain tumors in children.

Full Story: